About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNANCT03878186

Efficacy Of A Cognitive Behavioral Therapy To Decrease Threat Appraisal In HIV Participants Initiating Antiretroviral

Studies in the field of health and HIV indicate that threat appraisal is associated with poor adherence to treatment, anxiety, poor quality of life, avoidance behavior, less antiretroviral adherence, ...

Lead sponsor: National Institute of Medical Sciences and Nutrition, Salvador Zubiran•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

National Institute of Medical Sciences and Nutrition, Salvador Zubiran

Collaborators

Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•At least 18 years of age
•HIV diagnosis confirmed
•Naïve to antiretroviral treatment
•Threat appraisal greater than or equal to 40%
•Enrolled at INCMNSZ for medical care
•Be able to read and write
•Willing and able to provide written informed consent

Exclusion Criteria

•Psychotic symptoms
•Severe depression
•Severe anxiety
•Suicide risk
•Substance dependence
•Cognitive dysfunction
•Psychological or psychiatric treatment within previous 3 months
•Require emergency medical attention

Related studies

Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India

NCT07209917 · Cervical Cancer, Human Papillomavirus (HPV) Infection, and more

RECRUITINGPhase 1

A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV

NCT07392372 · HIV -1 Infection

An Effectiveness Trial of the PrEP for WINGS Study

NCT06853314 · HIV Infections, Alcohol Use Disorder, and more

Polypharmacy on Healthy Aging in People Living With HIV Over the Age of 75

NCT07388394 · Virus-HIV

Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young Adults

NCT06444360 · HIV

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 5, 2021Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment50

Start dateMar 2019

Last updatedMar 5, 2021

Condition

HIV Threat Appraisal

Locations shown

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

Mexico City

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 5, 2021Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions